PCM
XENT

Penn Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Penn Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,662
Closed -$857K – 233
2019
Q1 		$857K Buy
+26,662
New +$825K 0.08% 195
2017
Q3 		– Sell
-27,181
Closed -$760K – 282
2017
Q2 		$760K Sell
27,181
-39,515
-59% -$895K 0.06% 218
2017
Q1 		$1.14M Sell
66,696
-42,894
-39% -$601K 0.08% 198
2016
Q4 		$1.33M Sell
109,590
-1,003
-0.9% -$13K 0.08% 202
2016
Q3 		$1.75M Sell
110,593
-301
-0.3% -$4.53K 0.12% 178
2016
Q2 		$1.43M Buy
+110,894
New +$1.74M 0.08% 214

Other funds holding XENT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Penn Capital Management's XENT Position: Q2 2019 in Review

Penn Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 26,662 shares — an estimated $857K sold.

Penn Capital Management first reported a position in XENT in Q2 2016 and held it in 6 quarters. The position peaked at $1.75M in Q3 2016. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

  • Penn Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
  • Penn Capital Management sold 26,662 Intersect ENT, Inc shares in Q2 2019, an estimated $857K.
  • Penn Capital Management first reported a position in Intersect ENT, Inc in Q2 2016 and held it in 6 quarters.
  • Penn Capital Management's Intersect ENT, Inc position peaked at $1.75M in Q3 2016.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on Penn Capital Management's 13F filing for Q2 2019, filed 8 Aug 2019.